Pinnacle Associates’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$467K Buy
9,683
+355
+4% +$16.6K 0.01% 671
2025
Q4
$452K Sell
9,328
-396
-4% -$19.6K 0.01% 677
2025
Q3
$459K Sell
9,724
-638
-6% -$30.8K 0.01% 657
2025
Q2
$501K Sell
10,362
-512
-5% -$26.2K 0.01% 629
2025
Q1
$603K Buy
10,874
+158
+1% +$8.55K 0.01% 577
2024
Q4
$517K Sell
10,716
-1,361
-11% -$69.2K 0.01% 599
2024
Q3
$601K Buy
12,077
+798
+7% +$43.1K 0.01% 541
2024
Q2
$547K Buy
11,279
+58
+0.5% +$2.8K 0.01% 567
2024
Q1
$545K Sell
11,221
-856
-7% -$41.8K 0.01% 570
2023
Q4
$601K Sell
12,077
-406
-3% -$19.9K 0.01% 550
2023
Q3
$670K Sell
12,483
-9
-0.1% -$480 0.01% 513
2023
Q2
$673K Sell
12,492
-1,720
-12% -$92.5K 0.01% 527
2023
Q1
$773K Sell
14,212
-1,049
-7% -$51K 0.02% 454
2022
Q4
$739K Buy
15,261
+11
+0.1% +$483 0.02% 446
2022
Q3
$580K Buy
15,250
+978
+7% +$43.6K 0.01% 475
2022
Q2
$714K Sell
14,272
-60
-0.4% -$3.19K 0.02% 472
2022
Q1
$736K Sell
14,332
-301
-2% -$15.5K 0.01% 491
2021
Q4
$733K Buy
14,633
+168
+1% +$8.31K 0.01% 499
2021
Q3
$697K Sell
14,465
-623
-4% -$31.7K 0.01% 503
2021
Q2
$795K Buy
15,088
+18
+0.1% +$939 0.01% 474
2021
Q1
$745K Sell
15,070
-1,333
-8% -$64K 0.01% 461
2020
Q4
$797K Sell
16,403
-1,309
-7% -$64.6K 0.02% 433
2020
Q3
$889K Buy
17,712
+1,762
+11% +$90.7K 0.02% 388
2020
Q2
$814K Buy
15,950
+91
+0.6% +$4.42K 0.02% 405
2020
Q1
$693K Sell
15,859
-4,221
-21% -$202K 0.02% 399
2019
Q4
$1.01M Sell
20,080
-5,900
-23% -$276K 0.02% 409
2019
Q3
$1.2M Sell
25,980
-2,169
-8% -$93.5K 0.03% 370
2019
Q2
$1.22M Sell
28,149
-980
-3% -$41.7K 0.03% 369
2019
Q1
$1.29M Sell
29,129
-1,981
-6% -$84.9K 0.03% 364
2018
Q4
$1.35M Sell
31,110
-1,144
-4% -$50.5K 0.03% 347
2018
Q3
$1.44M Sell
32,254
-400
-1% -$17.1K 0.03% 357
2018
Q2
$1.31M Buy
32,654
+545
+2% +$21.5K 0.03% 367
2018
Q1
$1.29M Sell
32,109
-3,670
-10% -$153K 0.03% 365
2017
Q4
$1.54M Buy
35,779
+349
+1% +$16.1K 0.03% 340
2017
Q3
$1.76M Buy
35,430
+500
+1% +$24.2K 0.03% 326
2017
Q2
$1.67M Sell
34,930
-500
-1% -$23.9K 0.03% 328
2017
Q1
$1.6M Sell
35,430
-4,164
-11% -$177K 0.03% 340
2016
Q4
$1.6M Sell
39,594
-520
-1% -$20.5K 0.03% 334
2016
Q3
$1.53M Buy
40,114
+3,455
+9% +$139K 0.03% 329
2016
Q2
$1.53M Sell
36,659
-948
-3% -$38.9K 0.03% 325
2016
Q1
$1.51M Sell
37,607
-75
-0.2% -$3.01K 0.03% 314
2015
Q4
$1.61M Buy
37,682
+805
+2% +$37K 0.03% 299
2015
Q3
$1.75M Buy
36,877
+395
+1% +$20.1K 0.04% 291
2015
Q2
$1.81M Buy
36,482
+200
+0.6% +$10.1K 0.03% 297
2015
Q1
$1.79M Sell
36,282
-3,650
-9% -$175K 0.03% 292
2014
Q4
$1.82M Sell
39,932
-4,000
-9% -$194K 0.04% 290
2014
Q3
$2.48M Sell
43,932
-1,700
-4% -$91.3K 0.05% 263
2014
Q2
$2.43M Sell
45,632
-68,206
-60% -$3.62M 0.05% 262
2014
Q1
$5.95M Sell
113,838
-1,062
-0.9% -$53.8K 0.12% 164
2013
Q4
$6.16M Sell
114,900
-1,682
-1% -$86.8K 0.12% 167
2013
Q3
$5.9M Buy
116,582
+1,100
+1% +$56K 0.12% 164
2013
Q2
$5.95M Buy
+115,482
New +$6.15M 0.13% 158

Other funds holding SNY

Pinnacle Associates's SNY Position: Q1 2026 in Review

Pinnacle Associates increased its Sanofi (SNY) stake by 3.8% in Q1 2026, buying an estimated $16.6K and bringing the position to 9,683 shares worth $467K. The position accounts for 0.01% of the portfolio, ranked #671.

Pinnacle Associates first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.16M in Q4 2013. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Pinnacle Associates held 9,683 shares of Sanofi worth $467K as of Q1 2026.
  • Pinnacle Associates bought 355 Sanofi shares in Q1 2026, an estimated $16.6K.
  • Sanofi made up 0.01% of Pinnacle Associates's portfolio in Q1 2026, its #671 holding.
  • Pinnacle Associates first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
  • Pinnacle Associates's Sanofi position peaked at $6.16M in Q4 2013.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Pinnacle Associates's 13F filing for Q1 2026, filed 22 Apr 2026.